Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4937
Source ID: NCT01855243
Associated Drug: Regular Insulin
Title: Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01855243/results
Conditions: Diabetes Mellitus (DM)
Interventions: DRUG: regular insulin|DRUG: 70/30 insulin|DRUG: Glargine|DRUG: glulisine
Outcome Measures: Primary: Mean Daily Blood Glucose (BG) Concentration During Their Hospital Stay., during hospital stay which is expected to be average 3 weeks|Mean BG After First Day of Hospitalization, after first day of hospitalization | Secondary: Number of Patients Developed Hypoglycemic Events, Hypoglycemic episodes are classified as major (BG ≤ 40 mg/dL or associated with impaired mental status or loss of consciousness), or minor (BG between 40 and 59 mg/dL) events., during hospital stay which is expected to be average 3 weeks|Number of Patients Developed Episodes of Severe Hyperglycemia, Hyperglycemic events are defined as BG \> 300 mg/dL., during hospital stay which is expected to be average 3 weeks|Mortality Rate, during the hospital stay which is expected to be average 3 weeks
Sponsor/Collaborators: Sponsor: Cairo University
Gender: ALL
Age: ADULT
Phases:
Enrollment: 63
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2010-03
Completion Date: 2014-06
Results First Posted: 2019-01-15
Last Update Posted: 2019-01-15
Locations: the department of internal medicine, Cairo University teaching hospitals,, Cairo, Egypt
URL: https://clinicaltrials.gov/show/NCT01855243